Propanc Biopharma, Inc.: Form 10-Q for the period ended Mar 31, 2013
Filed with the SEC on May 20, 2013 and accepted by EDGAR at May 20, 2013, 14:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 9 months2012-07-01 to 2013-03-31 | $1.7k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2013-01-01 to 2013-03-31 | −$229.4k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-07-01 to 2013-03-31 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-01-01 to 2013-03-31 | $1.4k | us-gaap:InterestExpense |
| Interest expense | 9 months2012-07-01 to 2013-03-31 | $4.0k | us-gaap:InterestExpense |
| Income tax | 3 months2013-01-01 to 2013-03-31 | −$30 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2012-07-01 to 2013-03-31 | −$61.1k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-01-01 to 2013-03-31 | −$337.7k | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-07-01 to 2013-03-31 | −$1.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 9 months2012-07-01 to 2013-03-31 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2012-07-01 to 2013-03-31 | −$96.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | At period end2013-03-31 | $423 | us-gaap:AssetsCurrent |
| Total assets | At period end2013-03-31 | $4.1k | us-gaap:Assets |
| Current liabilities | At period end2013-03-31 | $752.0k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2013-03-31 | −$747.8k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001354488-13-003018. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.